COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS
申请人:Nanjing Zhengxiang Pharmaceuticals Co., Ltd.
公开号:US20220033416A1
公开(公告)日:2022-02-03
The invention provides compounds that may inhibit influenza virus replication, and are accordingly useful for treatment of viral infections caused by influenza virus. The invention further provides pharmaceutical compositions containing these compounds and methods of using these compounds to treat or prevent viral infections caused by influenza virus.
[EN] COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS<br/>[FR] COMPOSÉS S'UTILISANT POUR TRAITER LES INFECTIONS CAUSÉES PAR LE VIRUS DE LA GRIPPE
申请人:NANJING ZHENGXIANG PHARMACEUTICALS CO LTD
公开号:WO2021007506A1
公开(公告)日:2021-01-14
The invention provides compounds that may inhibit influenza virus replication, and are accordingly useful for treatment of viral infections caused by influenza virus. The invention further provides pharmaceutical compositions containing these compounds and methods of using these compounds to treat or prevent viral infections caused by influenza virus.